BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 17483818)

  • 1. The Sunshine Act: commercial conflicts of interest and the limits of transparency.
    Wilson M
    Open Med; 2014; 8(1):e10-3. PubMed ID: 25009680
    [No Abstract]   [Full Text] [Related]  

  • 2. Revisiting financial conflicts of interest in FDA advisory committees.
    Pham-Kanter G
    Milbank Q; 2014 Sep; 92(3):446-70. PubMed ID: 25199895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New FDA Advisory Team to Focus on AI, Other Digital Health Technologies.
    Harris E
    JAMA; 2023 Nov; 330(19):1828. PubMed ID: 37910089
    [No Abstract]   [Full Text] [Related]  

  • 4. Conflicts of Interest for Dietary Guidelines Advisory Committee Members: Neither a New Nor Unexplored Issue.
    Mialon M; Serodio P; Crosbie E; Teicholz N; Naik A; Carriedo A
    Adv Nutr; 2023 Sep; 14(5):1246-1247. PubMed ID: 37709369
    [No Abstract]   [Full Text] [Related]  

  • 5. Settling for second best?
    Pitts PJ
    Nat Biotechnol; 2007 Jul; 25(7):715-6. PubMed ID: 17621285
    [No Abstract]   [Full Text] [Related]  

  • 6. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 7. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 8. Advisory committees at FDA: the Hinchey Amendment and "conflict of interest" waivers.
    Lietzan E
    J Health Law; 2006; 39(4):415-49. PubMed ID: 17402656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Former FDA commissioner pleads guilty to two charges.
    Tanne JH
    BMJ; 2006 Oct; 333(7574):874. PubMed ID: 17068022
    [No Abstract]   [Full Text] [Related]  

  • 10. Probity gone nuts.
    Nat Biotechnol; 2007 May; 25(5):483. PubMed ID: 17483818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model-based benefit-risk assessment: can Archimedes help?
    Krishna R
    Clin Pharmacol Ther; 2009 Mar; 85(3):239-40. PubMed ID: 19223878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Task force 5: Expert testimony and opinions.
    Bonow RO; Zipes DP; Anderson JL; Cheitlin MD; Goldstein LB; Grant AO; Faxon D; Lima JA; Robertson RM
    J Am Coll Cardiol; 2004 Oct; 44(8):1747-9. PubMed ID: 15489119
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.